High efficacy and safety of CD38 and BCMA bispecific #CAR-T in relapsed or refractory multiple myeloma https://t.co/eqYO82T49S #CART #bmtsm #CARTcell #immunotherapy #tcellrx #CARTcells #CellTherapy
4,118 followers
258 followers
RT @celltherapynews: ⚕️ A clinical study conducted at the Second Affiliated Hospital of Yangtze University demonstrated the efficacy and sa…
152 followers
RT @celltherapynews: ⚕️ A clinical study conducted at the Second Affiliated Hospital of Yangtze University demonstrated the efficacy and sa…
11,738 followers
⚕️ A clinical study conducted at the Second Affiliated Hospital of Yangtze University demonstrated the efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory #MultipleMyeloma. https://t.co/PqwRpawjrx https://t.co/IRYMpcBebH